Scarica l'app Stockscreener
0.4925
0.94%
0.0046
Dopo l'orario di chiusura:
.47
-0.0225
-4.57%
Precedente Chiudi:
$0.4879
Aprire:
$0.4878
Volume 24 ore:
59,903
Relative Volume:
0.54
Capitalizzazione di mercato:
$2.20M
Reddito:
$23.45M
Utile/perdita netta:
$-19.98M
Rapporto P/E:
-0.0275
EPS:
-17.89
Flusso di cassa netto:
$-2.65M
1 W Prestazione:
+6.95%
1M Prestazione:
-8.80%
6M Prestazione:
-26.13%
1 anno Prestazione:
-22.56%
Intervallo 1D:
$0.48
$0.5053
Intervallo di 1 settimana:
$0.45
$0.5193
Portata 52W:
$0.42
$1.73
cbdMD Inc Stock (YCBD) Company Profile
Nome
cbdMD Inc
Settore
Telefono
704-445-5800
Indirizzo
4521 Sharon Road, Charlotte, NC
Confronta YCBD con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
YCBD
cbdMD Inc
|
0.4925 | 2.20M | 23.45M | -19.98M | -2.65M | -12.63 |
|
ZTS
Zoetis Inc
|
175.25 | 79.07B | 9.15B | 2.43B | 2.31B | 5.32 |
|
HLN
Haleon Plc Adr
|
9.66 | 43.68B | 14.26B | 1.55B | 0 | 0.3383 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.62 | 43.18B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
16.78 | 19.01B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
13.09 | 15.62B | 15.05B | -883.30M | 1.89B | -0.74 |
cbdMD Inc Borsa (YCBD) Ultime notizie
cbdMD (AMEX:YCBD) Stock Quotes, Forecast and News Summary - Benzinga
cbdMD Extends Lease on Executive Office and Warehouse By Investing.com - Investing.com Canada
cbdMD Extends Lease on Executive Office and Warehouse - Investing.com
CbdMD : Learn whether hemp cultivation and CBD production is truly sustainable by examining factors like water usage, soil health, and carbon footprint. - Marketscreener.com
CbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Barchart
cbdMD Launches THC Seltzers in $4B Market Push with Fast-Acting Technology | YCBD Stock News - StockTitan
cbdMD Launches Herbal Oasis Social Tonics, Hemp-Derived THC Seltzers - Yahoo Finance
CBD Life Sciences Inc. (CBDL) Applies for Beer & Liquor License to Sell CBD Wine - Quantisnow
YCBD stock touches 52-week low at $0.43 amid market challenges - Investing.com
CBD Life Sciences, Inc. (CBDL) Secures Breakthrough Walmart Marketplace Approval for 3000MG Pain Relief Cream, Setting the Stage for Unprecedented Growth - Quantisnow
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 2.5% – What’s Next? - Defense World
CBD Life Sciences, Inc. (CBDL) Announces Strategic MOU With U.S. Armed Forces for Groundbreaking Mushroom Supplement - Quantisnow
YCBD stock touches 52-week low at $0.44 amid market challenges By Investing.com - Investing.com South Africa
YCBD stock touches 52-week low at $0.44 amid market challenges - Investing.com
CBD Life Sciences Inc. (CBDL) Targets Alibaba as the Next Retail Giant for Wholesale Expansion of Top-Selling CBD Products - Quantisnow
CBD Life Sciences, Inc. (CBDL) Launches First-of-Its-Kind CBD Horse Paste: A Veterinarian-Designed Solution for Equine Wellness - Quantisnow
CBD Life Sciences Inc. (CBDL) Ignites Expanding Revenue Stream With RangeMe, Poised for Explosive Growth - Quantisnow
Top Podcasts Partner with cbdMD - cbdMD
cbdMD Launches Line of CBD Products with Wegmans Food Markets - Newsfile
cbdMD Joins Forces with Life Time - cbdMD
CBD Life Sciences, Inc. Unveils Groundbreaking Nutritional Supplement Infused With Mushroom Extracts, Set to Drive Revenue and Revolutionize Wellness - Quantisnow
Wegmans to start carrying cbdMD CBD products - Supermarket News
cbdMD (NYSEAMERICAN:YCBD) Stock Price Down 6.1% - Defense World
cbdMD secures trademark, amends agreements - Investing.com India
cbdMD secures trademark, amends agreements By Investing.com - Investing.com Australia
The Future of Hemp: Innovations in Sustainability - cbdMD
CBD Life Sciences, Inc. Expands Footprint With Proposed Strategic Acquisition of Interest in Two New York Cannabis Dispensaries - Quantisnow
cbdMD, Inc. Announces Acceptance of Compliance Plan by NYSE American - Yahoo Finance
cbdMD resolves lease obligations, anticipates gain - Investing.com India
cbdMD Reduces Operating Loss, Reports Positive Net Income For Q3 And 15% YoY Drop In Net Sales - Benzinga
cbdMD, Inc. (AMEX:YCBD) Q3 2024 Earnings Call Transcript - Insider Monkey
Earnings call: cbdMD reports Q3 results with focus on strategic growth - Investing.com Canada
cbdMD revenue falls 15%, but losses trimmed - Green Market Report
cbdMD Delivers on Sequential Revenue Growth and Positive Net Income for Q3 2024 - StockTitan
IM Cannabis, Organigram And Other Hot Cannabis Stocks Soon To Report Earnings, What Investors Need To Know Now - Benzinga
cbdMD, Inc. to Host Conference Call to Discuss Third Quarter of Fiscal 2024 Results - West Lorne Chronicle
cbdMD (NYSEAMERICAN:YCBD) Shares Up 5% - Defense World
cbdMD updates share count post-note conversions - Investing.com India
cbdMD submits plan to regain NYSE compliance - Investing.com
cbdMD submits plan to regain NYSE compliance By Investing.com - Investing.com Nigeria
cbdMD Announces Closing of $2.8 Million Underwritten Public Offering of Common Stock - Quantisnow
I Tested cbdMD Gummies—Here’s My Review - Forbes
cbdMD continues to build science despite lack of federal clarity - NutraIngredients-usa.com
cbdMD, Inc. (NYSEAMERICAN:YCBD) Short Interest Down 13.1% in June - Defense World
cbdMD Announces Publication of Human Clinical Trial - Shoreline Beacon
cbdMD Announces Publication of Human Clinical Trial Data - StockTitan
Shop Premium CBD Products for Your Pets - cbdMD
Shop Quality CBD Oil Drops & Tinctures - cbdMD
cbdMD announces notification of noncompliance with NYSE American listing standards - Seeking Alpha
cbdMD, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards - Yahoo Finance
Farm Bill 2024: 3 Stocks That Would Get Smoked if Hemp Ban Passes - InvestorPlace
cbdMD Inc Azioni (YCBD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.11%
0.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):